Daniel Meron > Latham & Watkins LLP > Silicon Valley, United States > Lawyer Profile
Latham & Watkins LLP Offices

140 SCOTT DRIVE
MENLO PARK
CA 94025
CALIFORNIA
United States
- Firm Profile
- Go to...
Daniel Meron

Position
Daniel Meron, Co-Chair of the Healthcare Services & Providers Industry Group and a former high-level official at both the Department of Justice and the Department of Health and Human Services, represents healthcare industry leaders in high-stakes government disputes. He served previously as Global Co-Chair of the firm’s Healthcare & Life Sciences Practice Group.
Daniel leverages an unmatched understanding of the subtleties inherent in litigation involving the DOJ and HHS to represent plans; providers; PBMs; specialty pharmacies; and pharmaceutical, biotech, and medical device manufacturers in:
-
- False Claims Act (FCA) and related civil investigations
- Legal challenges to the validity of agency regulations and policies
- Providing sophisticated compliance counseling
Daniel joined Latham from the US Department of Health and Human Services (HHS), where he served as General Counsel from 2006 to 2007. He advised department leadership on sensitive and high-priority matters involving all of the key statutes and regulations that HHS enforces, including the Food, Drug, and Cosmetic Act and the Medicare and Medicaid statutes, as well as the federal Anti-Kickback Statute.
As General Counsel, Daniel also worked closely with the Office of Inspector General to coordinate positions on enforcement matters relating to Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) statutes and regulations.
From 2003 to 2006, Daniel was the Principal Deputy Assistant Attorney General for the US Department of Justice’s Civil Division. He oversaw healthcare civil fraud (FCA) and off-label promotion prosecutions, as well as defense of FDA and CMS regulations, policies, and reimbursement decisions.
Daniel served as a law clerk to Justice Anthony M. Kennedy of the US Supreme Court and to Judge Laurence H. Silberman of the US Court of Appeals for the DC Circuit.
Lawyer Rankings
United States > Healthcare > Health insurers
The interdisciplinary team at Latham & Watkins LLP flexes its muscles across regulatory, transactional, and contentious healthcare law matters, notably representing some of the country’s most prominent health insurance carriers in high-stakes litigation. The group is led by a DC trio of John Manthei
, Ben Haas, and Jason Caron, and Chicago-based partner Terra Reynolds. The department has experience handling M&A and large-scale transactions in the healthcare space, managing lawsuits regarding Medicare Advantage regulation, and supporting clients facing government agency investigations and disputes, in addition to a range of other matters. Former General Counsel of the United States Department of Health and Human Services Daniel Meron contributes deep regulatory and investigatory expertise to the practice, and David Tolley assists insurers facing government investigations as well as representing them in court.
Lawyer Rankings
Top Tier Firm Rankings
- Insurance > Advice to policyholders
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Cartel
- International trade and national security > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Finance > Commercial lending
- Finance > Commercial lending: Advice to bank lenders
- Intellectual property > Copyright
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Healthcare > Life sciences
- Real estate > Land use/zoning
- Healthcare > Life sciences
- Healthcare > Life sciences
- Healthcare > Life sciences
- Healthcare > Life sciences
- Intellectual property > Patents: licensing
- Healthcare > Life sciences
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Antitrust > Merger control
- International trade and national security > National Security
- Intellectual property > Patents: licensing
- Healthcare > Life sciences
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- M&A/corporate and commercial > Shareholder activism
- Industry focus > Sport
- Finance > Structured finance: derivatives and structured products
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- M&A/corporate and commercial > Corporate governance
- International trade and national security > Customs, export controls and economic sanctions
- Industry focus > Education
- Energy > Energy regulation: electric power
- Energy > Energy regulation: oil and gas
- Government > Government contracts
- Insurance > Insurance: non-contentious
- Dispute resolution > International litigation
- Dispute resolution > Leading trial lawyers
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Financial services litigation
- Healthcare > Health insurers
- Media, technology and telecoms > Outsourcing
- Healthcare > Service providers
- Dispute resolution > International arbitration
- Dispute resolution > Leading trial lawyers
- Intellectual property > Trademarks: litigation
- Dispute resolution > Leading trial lawyers
- Finance > Financial services regulation
- Finance > Commercial lending > Advice to direct lenders/private credit
- Dispute resolution > Corporate investigations and white-collar criminal defense